Customized Educational Content Powered by Physician-Backed Cannvas.Me Platform

TORONTO, May 28, 2019 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce it has signed an agreement to be the exclusive provider of unbiased cannabis education for Liberty Leaf Holdings Ltd. (CSE: LIB) (OTC: LIBFF) (FSE: HN3P) (“Liberty Leaf”), who among other assets, is operating a cannabis accessories e-commerce platform, SignaturebyLibertyLeaf.com. The agreement calls for Cannvas to provide original evidence-based educational content, progressive learning modules and value-added services to the Liberty Leaf platform through white labeling solutions powered by the Cannvas.Me educational platform.

“We are thrilled to partner with Liberty Leaf to ensure their audiences have easy access to a library of unbiased cannabis education powered by the physician-backed and educator-approved Cannvas.Me digital learning platform,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech. “As we work toward our goal of becoming the leading third-party arm’s-length resource for unbiased information and education on cannabis, it’s encouraging to establish partnerships with companies like Liberty Leaf who understand the value of educating consumers and empowering them with the information to make beneficial cannabis choices.”

Under the terms of the agreement, Cannvas will provide subscription-based white-label educational services based on its original educational content, created and curated by its independent Medical, Educational and Cannabis Sciences Advisory Boards. Consideration for the services reflected in the agreement comes in the form of a 12-month paid subscription with an annual sum to be reviewed following each year and with ample room for expansion of services and offerings.

Liberty Leaf is a Canadian-based public company whose objective is to be at the forefront of the cannabis industry, accelerating the expansion of revenue-generating businesses within the rapidly growing sector. Its business strategy places Liberty Leaf’s vertically integrated legal cannabis grower/processor/distributor operations in the middle of an expected multibillion-dollar cannabis boom.

Will Rascan, Liberty Leaf’s President and Director, explained, “One of our mandates at Liberty Leaf is to take a leadership role in contributing to the cannabis community. Providing quality education around cannabis through our various platforms, including our Signature site, is a key way of doing that – and now, partnering with Cannvas MedTech, we can go ahead.”

“All the content we put out through Cannvas will be physician-backed and education-approved. That’s very important to us at Liberty Leaf,” Rascan stresses, “because we feel the community deserves, and it’s important for us to deliver, solid, reliable information.”

Rascan adds, “From a business perspective, providing quality content is not only the right thing to do, but differentiates Liberty Leaf in terms of how our brands are positioned.”

Once fully integrated with the Liberty Leaf platform, its audience will be able to access Cannvas.Me educational content from anywhere in the world, and Cannvas expects to work closely with Liberty Leaf’s partner network to source information and collaborate on articles to meet the needs of the communities it serves across Canada.

About Liberty Leaf Holdings Ltd.
Liberty Leaf is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added cannabidiol products and accessory products within this dynamic and fast-growing sector.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

SOURCE Cannvas MedTech Inc